Ugo Mayor

Dr. Ugo Mayor

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2003 in Nature
Verified
Journal Article
Closed access
UMUgo Mayor
Ugo Mayor
NGNicholas R. Guydosh
Nicholas R. Guydosh
CJChristopher M. Johnson
Christopher M. Johnson
JGJ. Günter Grossmann
J. Günter Grossmann
SSSatoshi Sato
Satoshi Sato
AFAlan R. Fersht
Alan R. Fersht

2 March 2018 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
JLJuliette J. Lee
Juliette J. Lee
ASAlvaro Sanchez-Martinez
Alvaro Sanchez-Martinez
AMAitor Martinez
Aitor Martinez
CBCristiane Benincá
Cristiane Benincá
UMUgo Mayor
Ugo Mayor
AWAlexander Whitworth
Alexander Whitworth
The Parkinson’s disease factors PINK1 and parkin are strongly implicated in stress-induced mitophagy in vitro, but little is known about their impact on basal mitophagy in vivo. We generated transgenic Drosophila melanogaster expressing fluorescent mitophagy reporters to evaluate the impact of Pink1/parkin mutations on basal mitophagy under physiological conditions. We find that mitophagy is readily detectable and abundant in many tissues, including Parkinson’s disease–relevant dopaminergic neurons. However, we did not detect mitolysosomes in flight muscle. Surprisingly, in Pink1 or parkin null flies, we did not observe any substantial impact on basal mitophagy. Because these flies exhibit locomotor defects and dopaminergic neuron loss, our findings raise questions about current assumptions of the pathogenic mechanism associated with the PINK1/parkin pathway. Our findings provide evidence that Pink1 and parkin are not essential for bulk basal mitophagy in Drosophila. They also emphasize that mechanisms underpinning basal mitophagy remain largely obscure.

21 November 2000 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
UMUgo Mayor
Ugo Mayor
CJChristopher M. Johnson
Christopher M. Johnson
VDValerie Daggett
Valerie Daggett
AFAlan R. Fersht
Alan R. Fersht
The Engrailed Homeodomain protein has the highest refolding and unfolding rate constants directly observed to date. Temperature jump relaxation measurements gave a refolding rate constant of 37,500 s −1 in water at 25°C, rising to 51,000 s −1 around 42°C. The unfolding rate constant was 1,100 s −1 in water at 25°C and 205,000 s −1 at 63°C. The unfolding half-life is extrapolated to be ≈7.5 ns at 100°C, which allows real-time molecular dynamics unfolding simulations to be tested on this system at a realistic temperature. Preliminary simulations did indeed conform to unfolding on this time scale. Further, similar transition states were observed in simulations at 100°C and 225°C, suggesting that high-temperature simulations provide results applicable to lower temperatures.

31 October 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Stefano GianniStefano Gianni
Stefano Gianni
NGNicholas R. Guydosh
Nicholas R. Guydosh
FKFaaizah Khan
Faaizah Khan
TCTeresa D. Caldas
Teresa D. Caldas
UMUgo Mayor
Ugo Mayor
AFAlan R. Fersht
Alan R. Fersht
We compare the folding of representative members of a protein superfamily by experiment and simulation to investigate common features in folding mechanisms. The homeodomain superfamily of three-helical, single-domain proteins exhibits a spectrum of folding processes that spans the complete transition from concurrent secondary and tertiary structure formation (nucleation-condensation mechanism) to sequential secondary and tertiary formation (framework mechanism). The unifying factor in their mechanisms is that the transition state for (un)folding is expanded and very native-like, with the proportion and degree of formation of secondary and tertiary interactions varying. There is a transition, or slide, from the framework to nucleation-condensation mechanism with decreasing stability of the secondary structure. Thus, framework and nucleation-condensation are different manifestations of an underlying common mechanism.

13 October 2005 in Nature
Verified
Journal Article
Closed access
PDF file
TRT. L. Religa
T. L. Religa
JMJ. S. Markson
J. S. Markson
UMUgo Mayor
Ugo Mayor
SFS. M. V. Freund
S. M. V. Freund
AFA. R. Fersht
A. R. Fersht

4 March 2015 in EMBO Reports
Verified
Journal Article
Open access
PDF file
JLJin‐Rui Liang
Jin‐Rui Liang
AMAitor Martinez
Aitor Martinez
JLJon Lane
Jon Lane
UMUgo Mayor
Ugo Mayor
MCMichael J Clague
Michael J Clague
SUSylvie Urbé
Sylvie Urbé
Mitochondria play a pivotal role in the orchestration of cell death pathways. Here, we show that the control of ubiquitin dynamics at mitochondria contributes to the regulation of apoptotic cell death. The unique mitochondrial deubiquitylase, USP30, opposes Parkin‐dependent ubiquitylation of TOM20, and its depletion enhances depolarization‐induced cell death in Parkin‐overexpressing cells. Importantly, USP30 also regulates BAX/BAK‐dependent apoptosis, and its depletion sensitizes cancer cells to BH3‐mimetics. These results provide the first evidence for a fundamental role of USP30 in determining the threshold for mitochondrial cell death and suggest USP30 as a potential target for combinatorial anti‐cancer therapy. ![][1] USP30, recently described to counteract Parkin E3 ligase activity on mitochondria, is shown to regulate the mitochondrial pathway of apoptotic cell death in response to Parkin overexpression and the broadly used BH3‐mimetic therapeutic compounds. [1]: pending:yes